Workflow
Aardvark Therapeutics (AARD) 2025 Conference Transcript

Aardvark Therapeutics (AARD) 2025 Conference September 03, 2025 11:30 AM ET Company ParticipantsJosh Schimmer - Managing DirectorTien Lee - CEO, Founder & DirectorJosh SchimmerAll right. I think we're ready to get started with our next session. I'm Josh Schumer from the Cantor Biotech Equity Research Team. Very pleased to introduce from Aardvark Therapeutics, Tien Li, Chief Executive Officer and Founder. Tien, give us a quick snapshot of Aardvark and we'll then dive into all things TAZ2R agonist.Tien LeeOka ...